PMC:7605643 / 20229-20494
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T114","span":{"begin":30,"end":33},"obj":"Body_part"},{"id":"T115","span":{"begin":44,"end":47},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Remdesivir was formulated for RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus but in current study we have proposed its probable targets in human system as well (Table 3) so that we can compare its therapeutic capability to N. sativa bioactive constituents."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T41","span":{"begin":69,"end":77},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Remdesivir was formulated for RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus but in current study we have proposed its probable targets in human system as well (Table 3) so that we can compare its therapeutic capability to N. sativa bioactive constituents."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T203","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T204","span":{"begin":148,"end":153},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"Remdesivir was formulated for RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus but in current study we have proposed its probable targets in human system as well (Table 3) so that we can compare its therapeutic capability to N. sativa bioactive constituents."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T136","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Remdesivir was formulated for RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus but in current study we have proposed its probable targets in human system as well (Table 3) so that we can compare its therapeutic capability to N. sativa bioactive constituents."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"413","span":{"begin":60,"end":64},"obj":"Gene"},{"id":"416","span":{"begin":69,"end":79},"obj":"Species"},{"id":"417","span":{"begin":148,"end":153},"obj":"Species"},{"id":"418","span":{"begin":232,"end":241},"obj":"Species"},{"id":"419","span":{"begin":0,"end":10},"obj":"Chemical"}],"attributes":[{"id":"A413","pred":"tao:has_database_id","subj":"413","obj":"Gene:43740578"},{"id":"A416","pred":"tao:has_database_id","subj":"416","obj":"Tax:2697049"},{"id":"A417","pred":"tao:has_database_id","subj":"417","obj":"Tax:9606"},{"id":"A418","pred":"tao:has_database_id","subj":"418","obj":"Tax:555479"},{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"MESH:C000606551"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Remdesivir was formulated for RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus but in current study we have proposed its probable targets in human system as well (Table 3) so that we can compare its therapeutic capability to N. sativa bioactive constituents."}